Axsome Therapeutics INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersNew York, NY
SAM.gov UEIKGMGGVWRZRW4
Axsome Therapeutics develops pharmaceutical products for central nervous system conditions. The company markets Auvelity (dextromethorphan-bupropion), Sunosi (solriamfetol), and Symbravo (meloxicam and rizatriptan), and is developing pipeline candidates AXS-05, AXS-12, and AXS-14 to treat conditions including depression, migraine, Alzheimer's disease agitation, excessive daytime sleepiness, narcolepsy, fibromyalgia, and smoking cessation.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Axsome Therapeutics INC | New York | NY | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.